|
HS Code |
634720 |
| Chemical Name | 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate |
| Molecular Formula | C9H8Cl2N3O |
| Molecular Weight | 244.09 g/mol |
| Appearance | White to off-white crystalline powder |
| Purity | Typically ≥98% |
| Solubility | Slightly soluble in water, soluble in common organic solvents |
| Melting Point | Information typically varies, approx. 70-90°C (experimental) |
| Boiling Point | Decomposes before boiling |
| Storage Conditions | Store in a cool, dry place away from light |
| Stability | Stable under recommended storage conditions |
| Synonyms | 2-Chloro-5-(chloromethyl)pyridine cyano methyl acetamidate |
As an accredited 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed 1 kg HDPE drum with tamper-evident cap, labeled with chemical name, hazard symbols, batch number, and handling instructions. |
| Container Loading (20′ FCL) | 20′ FCL: 160 drums (25 kg each) loaded on pallets; total net weight 4,000 kg; securely packed for international transport. |
| Shipping | **Shipping Description:** 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate ships in tightly sealed, labeled containers, protected from moisture and light. Classified as a hazardous chemical, it requires secure, upright packaging and compliance with local, national, and international transport regulations. Handle with certified personnel and provide proper documentation for safe transit. |
| Storage | **Storage Description:** Store 2-Chloro-5-chloromethyl pyridine cyano methyl acetamidate in a tightly sealed container, away from moisture, heat, and direct sunlight, in a cool, dry, well-ventilated area. Keep away from incompatible substances such as strong oxidizing agents and acids. Ensure proper labeling, and restrict access to authorized personnel. Use secondary containment to prevent accidental spills or leaks. |
| Shelf Life | The shelf life of 2-Chloro-5-chloromethyl pyridine cyano methyl acetamidate is typically 1–2 years when stored in cool, dry conditions. |
|
Purity 98%: 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate with purity 98% is used in pharmaceutical intermediate synthesis, where it ensures high reaction yield and product consistency. Molecular Weight 242.6 g/mol: 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate with a molecular weight of 242.6 g/mol is used in agrochemical formulation, where precise dosing and reproducible compound properties are achieved. Stability Temperature 40°C: 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate stabilized at 40°C is used in storage and transport of raw materials, where product degradation is minimized over extended periods. Particle Size <10 µm: 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate with particle size less than 10 µm is used in fine chemical blending operations, where improved homogeneity and dispersion rates are obtained. Melting Point 78°C: 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate with a melting point of 78°C is used in controlled-release agrochemical formulations, where optimized solidification and controlled matrix dissolution are achieved. |
Competitive 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturers shoulder a special responsibility in the chemical industry. The integrity of every lot and the precision of each molecule define the outcome for countless downstream users. Working directly with 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate (sometimes abbreviated for ease as CCPCMA), it becomes clear that this compound stands out beyond the typical offerings found in commercial catalogs. Rather than speaking in broad jargon, let's lay out the practical aspects and what sets this substance apart for chemists, developers, and industrial partners.
From our own syntheses and production routines, reliable purity determines more than just the data on a certificate of analysis. Regular QC cycles have demonstrated that tighter control over co-eluting isomers results in more predictable downstream yields during complex syntheses where CCPCMA serves as an intermediate. Production batches consistently deliver a CCPCMA product that rates at least 98.5% purity by HPLC, sometimes exceeding 99%. This level arose not because of arbitrary marketing targets but as an answer to process hurdles experienced directly in active ingredient syntheses and specialty material production. The physical state—fine, low-dusting crystalline solid—means improved handling in both high-throughput and pilot applications. No two days in the facility are ever the same; volatility and reactivity are always top of mind, so careful solvent control and tightly monitored drying atmospheres have minimized hydrolysis and contamination risk.
The utility of CCPCMA shows up most boldly during its conversion steps—particularly for pharmaceutical intermediates. Feedback from teams working in agrochemical research and contract manufacturing reinforces the importance of this molecule’s reactivity profile. The cyano substituent provides a distinct route for nucleophilic additions or cross-coupling reactions that fail with more sterically hindered pyridines, enabling routes that would otherwise clog up with side products. The dual chloro and chloromethyl groups offer two independent levers for further derivatization, and we’ve watched customers unlock entirely new routes for both ring extension and side-chain elaboration. Distributors rarely see the challenges that arise with less pure or less robust analogs; those failures arrive in the form of returned product or synthesis breakdowns that stall projects. Out of this daily reality came the urge to refine our process parameters and offer a compound that truly stands up to multistep transformations.
Sitting at the crux of custom synthesis work, even minor impurities in CCPCMA tend to snowball further down the pipeline. We still see many labs grappling with off-brand alternatives, usually produced at lower cost to shave margin for distributors. Aside from visible color impurities—an instant red flag in this chemistry—the true differences reveal themselves when evaluating byproducts, solubility shifts, and yield losses in later reactions. We’ve documented cases where trace starting materials or catalyst residues result in rapid decomposition under standard cyclization conditions, leaving R&D chemists with nothing but failed experiments and wasted weeks.
Those seeking reliable, predictable outcomes make purity and traceability non-negotiable. There are plenty of vendors happy to offer “lowest price per kilo” options, with little to say about true reproducibility. Direct-from-manufacturer access to analytical records and synthesis backstory provides a much clearer audit trail, which has helped our partners pass regulatory and QA hurdles at the other end of the chain.
Manufacturing CCPCMA isn’t an exercise in simple scale-up. As volumes increase, previously minor variables become major factors. Early experiments on the pilot plant line revealed subtle issues with slow crystallization and solvent retention. These might sound arcane until they manifest as a sludge in reactors meant for high-throughput processing, or as compromised filterability in multipurpose plants. Each round of improvement—tweaking the precipitant, refining the order of reagent additions, and implementing stricter moisture controls—made a measurable difference in the overall consistency of the product delivered. These hands-on details don’t always get highlighted in commercial spec sheets, but in real-world manufacturing, they define the line between an acceptable material and one that genuinely supports innovation.
Our site carries an atmosphere of problem-solving, not mere compliance. The team often reflects on how one plant operator’s suggestion eliminated a bottleneck in the drying step, which has since become a permanent part of our SOP. That institutional memory, built from daily experience, ultimately forms the foundation on which customers place trust—trust that doesn’t evaporate at the first sign of trouble.
Chemists in both small-scale research and full production facilities look for intermediates that minimize risk and maximize output—not just in terms of quantity, but also in terms of reproducibility and purity. In our own role as manufacturer, attention gets paid not just to the end purity but to how each process step interacts with standard lab practices. For CCPCMA, the decision to maintain a consistent particle size allows for smoother weighing and dispersal in automated feed systems, crucial when running multiple 100-liter reactors in parallel. Stability during storage and transport counts for even more when facing long lead times or global distribution pipelines.
Requests for specific particle size distributions or extended shelf-life gave us an opportunity to innovate packaging and drying protocols. The genuine satisfaction comes not simply from meeting a written standard, but from hearing back that production lines stayed on schedule or R&D milestones progressed without the hurdles others experience. Regulatory inspection readiness follows from this baseline of consistency; we see fewer queries from auditors because the documentation and batch traceability support deeper confidence in the material itself.
Buyers accustomed only to price-driven sourcing often miss the cost of downtime inflicted by unstable material from anonymous suppliers. Multiple end users have described scenarios where a slight change in intermediate quality caused downstream reaction halts, especially in multi-step syntheses of proprietary actives or pilot-scale production for registration batches. Through repeated conversations with chemists leading these projects, a consistent theme emerges: they look for intermediates that reduce the risk of rework, not just lower up-front expenditure. Working backward from these needs, our QC teams validate CCPCMA against every critical property—chemical identity, residual solvents, particle size distribution—long before it ever leaves our hands.
It surprises some buyers to learn that the same product can differ drastically in performance, simply due to variation in byproduct profile or heterogeneity between lots. Our own analytic data has, in several cases, highlighted impurity spikes correlated with filter media breakdown from certain third-party suppliers, issues subsequently resolved by investment in higher-grade media and upgrades in our own purification protocols. Results show up where it counts: fewer bottle-necks on the customer side, fewer failed QC inspections, and shorter lead times from order to application.
We rarely adopt a “make it and move on” mindset. Instead, our teams view the lifecycle of CCPCMA in terms of the entire chain of value creation, from synthesis through application. This perspective grows out of years spent addressing unexpected variables—variations in raw material quality, equipment maintenance that lags behind demand, or even environmental shifts such as seasonal changes in humidity influencing yields. Lessons here don’t just reside in SOP manuals; they surface in shop-floor meetings and during direct customer visits.
One recent improvement stemmed from feedback on the challenges encountered when scaling up beyond the usual kilo-lab range—a customer’s team found crystallization rates shifted dramatically, producing fines that complicated their own filtration systems. They reported back and shared samples, and over a four-month period we adapted our own crystallizer design and solvent regimen to support a broader particle size range. The feedback loop with actual users forms a critical guardrail against complacency, reminding us every lot supports more than balance sheets—it supports research breakthroughs, new product registrations, and progress toward more sustainable chemistries.
Like many industries, chemical manufacturing faces mounting pressure to elevate safety and address environmental impact. The structure of 2-Chloro-5-Chloromethyl Pyridine Cyano Methyl Acetamidate includes reactive functions necessitating genuine respect during handling. Our decision to staff every shift with trained process safety engineers came after a near-miss incident during transfer between reactor and drying units. Since then, investment in more advanced vapor containment systems and real-time monitoring for vented emissions has enhanced both worker safety and compliance, and lessened unforeseen batch loss.
Waste handling—particularly management of spent solvents and mother liquors—became a focus point. Instead of seeking shortcuts, we created recycling loops that reclaim a significant portion of inputted solvents. Our full-time EHS staff monitor and optimize these processes continuously, creating tangible value both for our own process economics and for our stakeholders concerned about the environmental footprint of fine chemical production. As a result, downstream customers increasingly ask for not just end-product specs, but data on how their inputs were produced—our readiness to supply that information allows for more transparency throughout the value chain.
The most rewarding relationships we’ve built with users of CCPCMA extend beyond a single PO or one-off project. Direct contact with manufacturing and R&D teams on the user side allows us to address bottlenecks and anticipate upcoming needs. In many cases, problem-solving starts even before the first shipment leaves our plant—collaborative development on analytical methods tailored to users’ in-house protocols, or scheduling deliveries to align with campaign-based syntheses to optimize their own plant uptime.
We recall a memorable collaboration with a pharmaceutical firm running late-stage development on a new active. Their requirements evolved almost weekly, with changes to both tolerance for certain byproducts and preferred grade packaging formats. Open lines of dialogue allowed us to flexibly adjust production planning, source certified raw material inputs, and deploy additional purification steps for limited lots. This blend of nimble manufacturing and transparent communications distinguishes manufacturer-direct supply from more generic, catalog-style distribution.
Documentation—full transparency around production, analysis, and purity—often becomes a pivotal differentiator. As manufacturers, we understand that “meets minimum specification” rarely placates an auditor or provides reassurance for regulated applications. Our documentation includes original chromatograms, detailed impurity profiles, and records of every QC point throughout synthesis and finishing. Users working in regulated spaces such as agrochemicals and pharmaceuticals benefit directly: regulatory submissions move forward with less friction, and their own QA departments gain usable context, not just bare minimum numbers or generic declarations.
This approach results from hard lessons, such as when a critical shipment was held at customs for documentary gaps by a third-party testing authority. From that point recalibration of our recordkeeping processes created a more robust information trail, substantially reducing repeated delays and costly resampling for our downstream partners.
Play a role in creative problem-solving—this has become an unofficial motto in our plant. The distinct reactivity of CCPCMA often sparks innovation among users; the dual functionalization pattern opens up synthetic windows that single-chloro or non-cyano pyridines simply cannot match. Partnering with end users, we've seen the compound help surmount roadblocks in both heterocycle construction and amide bond formation under milder conditions. Time saved in lab development translates quickly into faster product launches, improved patent positions, and new commercializable products for our partners.
Beyond academic or process chemistry, this means more robust timelines for generating new agrochemical candidates or expanding a pharmaceutical product's lifecycle. Collaboration around how our CCPCMA performs in unconventional solvent systems or at scale gives us feedback cycles, helping us to tighten up future production and design next-generation intermediates that address emergent needs. The recognition that synthetically meaningful innovation only happens with reliable building blocks keeps our motivation fresh.
Supply chain disruptions hit every manufacturer at some point, particularly those producing specialty intermediates with restricted raw material access. Over the years, fluctuations in pyridine and cyanide precursor prices threw planning cycles into disarray. We responded by developing secondary sourcing agreements and stockpiling critical reagents not as mere insurance, but as a necessary stride towards continuity of supply.
Logistics isn’t just about on-time dispatch. Sensitivity to temperature, humidity, shock, or rough handling can complicate transit, and we’ve made a point of investing in validated shipping protocols, weather-resistant containers, and personalized scheduling with global freight partners. These measures limit quality drift and batch rejections on arrival; they also signal to receiving teams that quality does not terminate at the loading dock, it travels with each barrel and box direct to the user’s door.
Direct manufacturing means learning from every batch and responding to every failure. Each improvement isn’t just an algorithmic upgrade, but a record of hands-on troubleshooting, fielded by operators whose entire focus centers on improving the experience of our downstream users. This translates to a keener understanding of the stress points in typical research and production processes, and in knowing where small gains in purity, or drying, or byproduct removal pay forward into more ambitious science.
When new requests arise—be it for tighter impurity thresholds, special aliquot packaging, or changes in procedural documentation—the direct manufacturer brings practical wisdom to the dialogue. Rather than fitting requests into prefabricated “one-size-fits-all” frameworks, the approach grows out of a history of customization and adaptation.
The future of specialty intermediates like CCPCMA depends on adaptability and a persistent drive to solve problems alongside users, not for them. As chemistries grow more complex, and as demands for traceability, sustainability, and compliance increase, the hands-on knowledge developed on the manufacturer’s floor grows in importance. Every request for analytical support, special documentation, or formulation advice strengthens the link between supplier and user. This deepening relationship not only helps safeguard the reliability and innovative potential of the compound but also empowers end-users to move confidently into new chemical spaces, secure in the knowledge that their building blocks rest on a foundation of both technical excellence and genuine manufacturing care.